1. "Andrew Zelenetz"
  2. "Daniel Filippa"
Formats
  1. Journal Article (12)
  2. Meeting Abstract (10)
Groups
  1. Center for Hematologic Malignancies (22)
  2. Department of Medicine (22)
  3. Hematologic Malignancies, Division of (22)
  4. Lymphoma (22)
  5. Survivorship Research (10)
  6. Radiation Oncology, Department of (7)

More Groups

People
  1. Andrew Zelenetz (22)
  2. Daniel Filippa (22)
  3. Julie Feldstein (11)
  4. Ariela Noy (9)
  5. Craig Moskowitz (9)
  6. Carol Portlock (8)

More People

Years
  1. 2012 (1)
  2. 2010 (2)
  3. 2008 (1)
  4. 2007 (2)
  5. 2006 (1)
  6. 2004 (5)

More Years

Publications
  1. Blood (8)
  2. Journal of Clinical Oncology (3)
  3. Annals of Oncology (2)
  4. British Journal of Haematology (2)
  5. Proceedings of the American Association for Cancer Research Annual Meeting (2)
  6. Applied Immunohistochemistry & Molecular Morphology (1)

More Publications

Publishers
  1. American Society of Hematology (8)
  2. American Association for Cancer Research (3)
  3. American Society of Clinical Oncology (3)
  4. John Wiley & Sons (2)
  5. Oxford University Press (2)
  6. Lippincott Williams & Wilkins (1)

More Publishers

Results (22)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Expert second-opinion pathology review of lymphoma in the era of the World Health Organization classification
    Journal Article

    Matasar, M. J.; Shi, W.; Silberstein, J.; Lin, O.; Busam, K. J.; Teruya-Feldstein, J.; Filippa, D. A.; Zelenetz, A. D.; Noy, A.
    Annals of Oncology (2012)

    Fulltext@MSK | Save
  • High-dose chemo-radiotherapy for relapsed or refractory Hodgkin lymphoma and the significance of pre-transplant functional imaging: Research paper
    Journal Article

    Moskowitz, C. H.; Yahalom, J.; Zelenetz, A. D.; Zhang, Z.; Filippa, D.; Teruya-Feldstein, J.; Kewalramani, T.; Moskowitz, A. J.; Rice, R.; Maragulia, J.; more...
    British Journal of Haematology (2010)

    Fulltext@MSK | Save
  • Risk-adapted dose-dense immunochemotherapy determined by interim FDG-PET in advanced-stage diffuse large B-cell lymphoma
    Journal Article

    Moskowitz, C. H.; Schoder, H.; Teruya-Feldstein, J.; Sima, C.; Iasonos, A.; Portlock, C. S.; Straus, D.; Noy, A.; Palomba, M. L.; O'Connor, O. A.; more...
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Involved-field radiotherapy before high-dose therapy and autologous stem-cell rescue in diffuse large-cell lymphoma: Long-term disease control and toxicity
    Journal Article

    Hoppe, B. S.; Moskowitz, C. H.; Filippa, D. A.; Moskowitz, C. S.; Kewalramani, T.; Zelenetz, A. D.; Yahalom, J.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Expert second opinion pathology review of lymphoma in the era of the World Health Organization classification
    Meeting Abstract

    Matasar, M. J.; Shi, W. J.; Silberstein, J.; Feldstein, J. T.; Filippa, D.; Zelenetz, A. D.; Noy, A.
    Blood (2007)

    Fulltext@MSK | Save
  • Practice patterns in the diagnosis of follicular lymphoma (FL): Report from the National Lymphocare Study (NLCS)
    Meeting Abstract

    Matasar, M. J.; Saxena, R.; Wong, E. K.; Filippa, D. A.; Zelenetz, A. D.
    Blood (2007)

    Fulltext@MSK | Save
  • Chromosome-change based gene expression analysis reveals differentially expressed genes/pathways associated with histologic progression and transformation in follicular lymphoma
    Meeting Abstract

    Nanjangud, G.; Naresh, K.; Teruya-Feldstein, J.; Filippa, D.; Zelenetz, A.; Chaganti, R. S. K.
    Cancer Research (2006)

    Fulltext@MSK | Save
  • The follicular lymphoma international prognostic index (FLIPI) is superior to WHO/REAL histological grade for identifying high-risk patients: A retrospective review of the MSKCC experience in 260 patients with follicular lymphoma
    Meeting Abstract

    Halaas, J. L.; Teruya-Feldstein, J.; Filippa, D. A.; Moskowitz, C.; Naresh, K. N.; Zelenetz, A. D.
    Blood (2004)

    Fulltext@MSK | Save
  • Adverse prognostic significance of CD20 positive Reed-Sternberg cells in classical Hodgkin's disease
    Journal Article

    Portlock, C. S.; Donnelly, G. B.; Qin, J.; Straus, D.; Yahalom, J.; Zelenetz, A.; Noy, A.; O'connor, O.; Horwitz, S.; Moskowitz, C.; more...
    British Journal of Haematology (2004)

    Fulltext@MSK | Save
  • Rituximab and ICE as second-line therapy before autologous stem cell transplantation for relapsed or primary refractory diffuse large B-cell lymphoma
    Journal Article

    Kewalramani, T.; Zelenetz, A. D.; Nimer, S. D.; Portlock, C.; Straus, D.; Noy, A.; O'connor, O.; Filippa, D. A.; Teruya-Feldstein, J.; Gencarelli, A.; more...
    Blood (2004)

    Fulltext@MSK | Save